S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News

$22.86
-0.39 (-1.68%)
(As of 04:33 PM ET)
Compare
Today's Range
$22.69
$22.96
50-Day Range
$21.26
$24.54
52-Week Range
$12.78
$26.95
Volume
619,455 shs
Average Volume
789,553 shs
Market Capitalization
$13.41 billion
P/E Ratio
21.57
Dividend Yield
1.84%
Price Target
$28.45

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Hold
1.78 Rating Score
Upside/​Downside
24.5% Upside
$28.45 Price Target
Short Interest
Healthy
0.26% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.48mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
29.31%
From $1.16 to $1.50 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Medical Sector

44th out of 986 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

1st out of 9 stocks


FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Trade Smarter: Discover Hidden Opportunities w/ A.I.
There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.
See More Headlines

FMS Price History

FMS Company Calendar

Last Earnings
5/09/2023
Ex-Dividend for 6/1 Dividend
5/17/2023
Dividend Payable
6/01/2023
Today
6/09/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,235
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$28.45
High Stock Price Forecast
$51.80
Low Stock Price Forecast
$11.70
Forecasted Upside/Downside
+25.2%
Consensus Rating
Hold
Rating Score (0-4)
1.78
Research Coverage
9 Analysts

Profitability

Net Income
$709.50 million
Pretax Margin
5.72%

Debt

Sales & Book Value

Annual Sales
$20.44 billion
Cash Flow
$4.93 per share
Book Value
$27.74 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.33 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Helen Giza
    Chief Executive & Financial Officer
  • Franklin W. Maddux
    Global Chief Medical Officer
  • Dominik Heger
    Senior VP, Head-IR & Corporate Communications
  • William Valle
    Chief Executive Officer-North America
  • Katarzyna Mazur-Hofsaess
    Chief Executive Officer-Care Enablement













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 2 sell ratings and 7 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

9 Wall Street research analysts have issued twelve-month price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $11.70 to $51.80. On average, they anticipate the company's stock price to reach $28.45 in the next year. This suggests a possible upside of 25.2% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 on January 1st, 2023. Since then, FMS stock has increased by 39.0% and is now trading at $22.72.
View the best growth stocks for 2023 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,510,000 shares, a decrease of 7.9% from the April 30th total of 1,640,000 shares. Based on an average daily volume of 900,300 shares, the days-to-cover ratio is currently 1.7 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings data on Tuesday, May, 9th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.10. The firm earned $5.05 billion during the quarter, compared to the consensus estimate of $4.98 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 5.44% and a net margin of 3.06%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Wednesday, May 3rd. Investors of record on Thursday, May 18th will be paid a dividend of $0.7086 per share on Thursday, June 1st. This represents a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, May 17th.
Read our dividend analysis for FMS
.

What ETFs hold Fresenius Medical Care AG & Co. KGaA's stock?
Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.82%. The dividend payout ratio is 39.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 28.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (3.41%), Dodge & Cox (0.72%), Balyasny Asset Management L.P. (0.13%), Arrowstreet Capital Limited Partnership (0.12%), BlackRock Inc. (0.08%) and Two Sigma Advisers LP (0.04%).

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $22.72.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $13.33 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.06 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 1,235 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -